Clinical Trials Browser

NETWORK × Breast Neoplasms × Bevacizumab × Clear all

NCT00028990 2023-06-15

Paclitaxel With or Without Bevacizumab in Treating Patients With Locally Recurrent or Metastatic Breast Cancer

Phase 3 Completed

Breast Neoplasms, Breast Neoplasms, Male

NCT00887536 2022-04-20

A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer

Phase 3 Completed

Adenocarcinoma, Breast Diseases, Breast Neoplasms, Carcinoma

NCT00464646 2021-10-25

Therapy With Bevacizumab (BEV), Epirubicin, and Cyclophosphamide Followed by Docetaxel Plus Trastuzumab and BEV Given as Neoadjuvant or Adjuvant Therapy for Women With Locally Advanced HER2 Positive Invasive Breast Cancer

Phase 2 Completed

105 enrolled 17 charts

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT00625898 2020-09-10

BETH

Phase 3 Terminated

Breast Neoplasms

NCT01935492 2020-01-18

Stop&Go

Phase 3 Completed

Breast Neoplasms

NCT00911716 2019-08-01

TC Avastin. ICORG 08-10, V6

Phase NA Completed

Breast Neoplasms, Breast Neoplasms, Male

NCT00408408 2017-09-18

Chemotherapy With or Without Bevacizumab in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer That Can Be Removed By Surgery

Phase 3 Unknown

1,206 enrolled 19 charts

Breast Neoplasms

NCT01367028 2014-05-13

ABCSG 32

Phase 2 Completed

Breast Neoplasms